DSE : NAVANAPHAR

Navana Pharmaceuticals PLC — Reports

Pharmaceutical Preparations · Bangladesh

Last price 59.3 BDT (At close: Oct 29, 2026) · Market cap 6.37B

Latest research: Navana Pharmaceuticals financial analysis: 28% sales growth, BDT 750m interest bill and falling debt (Oct 2026) · Navana Pharmaceuticals: sales up 28% and factories at 98% of capacity, but interest takes half of operating profit

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Reports

75 annual and quarterly reports of Navana Pharmaceuticals PLC (NAVANAPHAR) as PDF.